Skip to main content

Table 1 Characteristics of the study population: non-sudden cancer deaths ( N= 2037)

From: Care provided and care setting transitions in the last three months of life of cancer patients: a nationwide monitoring study in four European countries

Characteristics Belgium (N = 595) The Netherlands (N = 335) Italy (N = 830) Spain (N = 277) p-valueb
  N(%) N(%) N(%) N(%)  
Age group      .156
18-64 160(27.1) 90(26.9) 195(23.5) 59(21.3)  
65-74 131(22.2) 94(28.1) 210(25.3) 65(23.5)  
75-84 184(31.2) 103(30.7) 257(31.0) 97(35.0)  
85 or above 115(19.5) 48(14.3) 168(20.2) 56(20.2)  
Mean 72.5 71.9 73.6 74.2  
Gender      <.001
M 328(55.1) 177(53.2) 448(54.0) 186(67.6)  
F 267(44.9) 156(46.8) 382(46.0) 89(32.4)  
Types of malignancy      <.001
Lung 148(24.9) 80(25.0) 182(26.5) 53(19.8)  
Breast 51(8.6) 33(10.3) 57(8.3) 11(4.1)  
Colorectal 69(11.6) 38(11.9) 102(14.8) 49(18.3)  
Prostate 25(4.2) 23(7.2) 35(5.1) 29(10.8)  
Other 302(50.8) 146(45.6) 312(45.3) 126(47.0)  
Longest place of residence in the last year     <.001  
Home or with family 516(87.2) 300(90.6) 799(96.5) 258(95.2)  
Care home 65(11.0) 30(9.1) 21(2.5) 10(3.7)  
Other 11(1.9) 1(0.3) 8(1.0) 3(1.1)  
Place of death      <.001
Home 196(33.2) 194(57.9) 377(45.5) 139(51.1)  
Nursinghome/Residential home for older people 71(12.0) 28(8.4) 41(5.0) 11(4.0)  
Hospital 198(33.5) 58(17.3) 312(37.7) 95(34.9)  
Palliative Care Unit/Hospice 122(20.6) 54(16.1) 94(11.4) 26(9.6)  
Elsewhere 4(0.7) 1(0.3) 4(0.5) 1(0.4)  
  1. aMissing for age group: n = 5, gender: n = 4, Type of malignancy: n = 166, Longest place of residence last year: n = 15, Place of death: n = 11.
  2. bχ2test on cross-country differences.